Therapeutic Targets in Chronic Lymphocytic Leukemia

被引：3
|
作者：
Laurenti, Luca [1 ]
Efremov, Dimitar G. [2 ]
机构：
[1] Fdn Policlin Univ A Gemelli IRCCS, Dept Hematol, I-00168 Rome, Italy
[2] Int Ctr Genet Engn & Biotechnol, Mol Hematol, I-34149 Trieste, Italy
来源：
CANCERS | 2020年 / 12卷 / 11期
关键词：
IBRUTINIB RESISTANCE; CLONAL EVOLUTION; DE-NOVO; VENETOCLAX; CLL; DISEASE; BTK; INHIBITION;
D O I：
10.3390/cancers12113259
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] Chronic lymphocytic leukemia: 2022 update on diagnostic and therapeutic procedures
    Hallek, Michael
    Al-Sawaf, Othman
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (12) : 1679 - 1705
  • [42] Pathogenesis of chronic lymphocytic leukemia and the development of novel therapeutic strategies
    Kikushige, Yoshikane
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2020, 60 (04) : 146 - 158
  • [43] Cell Penetrating Peptides as a Therapeutic Strategy in Chronic Lymphocytic Leukemia
    Arrouss, Issam
    Decaudin, Didier
    Choquet, Sylvain
    Azar, Nabih
    Parizot, Christophe
    Zini, Jean M.
    Nemati, Fariba
    Rebollo, Angelita
    PROTEIN AND PEPTIDE LETTERS, 2015, 22 (06): : 539 - 546
  • [44] Targeting Mitochondrial Bioenergetics as a Therapeutic Strategy for Chronic Lymphocytic Leukemia
    Chowdhury, Subir Roy
    Banerji, Versha
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2018, 2018
  • [45] PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia
    Spaner, D. E.
    Lee, E.
    Shi, Y.
    Wen, F.
    Li, Y.
    Tung, S.
    McCaw, L.
    Wong, K.
    Gary-Gouy, H.
    Dalloul, A.
    Ceddia, R.
    Gorzcynski, R.
    LEUKEMIA, 2013, 27 (05) : 1090 - 1099
  • [46] Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscape
    Burger, Jan A.
    CURRENT OPINION IN ONCOLOGY, 2012, 24 (06) : 643 - 649
  • [47] PPAR-alpha is a therapeutic target for chronic lymphocytic leukemia
    D E Spaner
    E Lee
    Y Shi
    F Wen
    Y Li
    S Tung
    L McCaw
    K Wong
    H Gary-Gouy
    A Dalloul
    R Ceddia
    R Gorzcynski
    Leukemia, 2013, 27 : 1090 - 1099
  • [48] Epigenetic profiling in chronic lymphocytic leukemia reveals novel methylation targets
    Rush, LJ
    Raval, A
    Funchain, P
    Johnson, AJ
    Smith, L
    Lucas, DM
    Bembea, M
    Liu, TH
    Heerema, NA
    Rassenti, L
    Liyanarachchi, S
    Davuluri, R
    Byrd, JC
    Plass, C
    CANCER RESEARCH, 2004, 64 (07) : 2424 - 2433
  • [49] NORMAL AND CHRONIC LYMPHOCYTIC-LEUKEMIA LYMPHOCYTES AS TARGETS FOR HUMAN COMPLEMENT
    LOGUE, GL
    HUANG, AT
    JOURNAL OF IMMUNOLOGY, 1978, 120 (05): : 1784 - 1784
  • [50] A COMPARISON OF CHRONIC LEUKEMIC LYMPHOCYTIC LEUKEMIA, CHRONIC SUBLEUKEMIC LYMPHOCYTIC LEUKEMIA, AND LYMPHOCYTIC SARCOMA
    BIGLEY, RH
    KOLER, RD
    PIROFSKY, B
    OSGOOD, EE
    CANCER CHEMOTHERAPY REPORTS, 1962, (16): : 231 - 234
12345